A ten year review of Jadelle contraceptive use at Rivers State University Teaching Hospital, south south Nigeria
Department of Obstetrics and Gynaecology, Rivers State University Teaching Hospital, Port Harcourt.
Research Article
World Journal of Advanced Research and Reviews, 2020, 05(01), 116-121
Article DOI: 10.30574/wjarr.2020.5.1.0009
Publication history:
Received on 07 January 2020; revised on 12 January 2020; accepted on 20 January 2020
Abstract:
Norplant-2 (Jadelle) is an effective long acting hormonal contraceptive method. It is highly acceptable and safe with efficacy equivalent to sterilization. To determine the uptake rate, socio-demographic characteristics of the acceptors of Jadelle contraceptive method and its pattern of use at the RSUTH. This is a retrospective observational study in which patients’ records in family planning clinic at the Rivers State University Teaching Hospital (RSUTH) over a period of ten years were reviewed; data extracted, coded and analyzed in statistical package for social sciences (SPSS) IBM version 25.0 (Armonk NY). The prevalence rate of Jadelle contraceptive among contraceptive acceptors at the RSUTH is 13.4 %. The mean age and range of the acceptors of jadelle contraceptive were 33.43 SD 4.9 years and 19-49 years respectively. The modal age group was 30-34 years. Majority of the clients had secondary level of education 185 (73.1 %) followed by tertiary education 44 (17.4%) while 7 (2.8%) had no formal education. Of the 253 acceptors of jadelle, greater than two third 176 (69.5%) were multipara. Most of the clients were married 248 (98%) and of Christian religion 238 (94%). The uptake of Jadelle over the study period was low. Adequate counseling and public enlightenment are needed for an improvement in its uptake in our environment.
Keywords:
Contraception; Jadelle; Acceptors; RSUTH.
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0